Data-Driven Drug Discovery Platform "RePhaIND®" to be Presented at the Pharmaceutical Society of Japan Annual Meeting
2025/3/14
GEXVal Inc.March 14, 2025 Data-Driven Drug Discovery Platform "RePhaIND®︎" to be Presented at the Pharmaceut […]
Series C Round Completed, Securing a Total of JPY 910 Million
2025/2/21
GEXVal Inc.February 21, 2025 Series C Extension Round Completed: Achieved Total Series C Funding of JPY 910 Mi […]
Our pipeline information has been updated
2025/2/14
GEXVal Inc.February 14, 2025 Our pipeline information has been updated. Pipeline - GEXVal For further informat […]
GEXVal Receives Funding from a Parkinson’s Research Program at The Michael J. Fox Foundation
2025/2/14
GEXVal Inc.February 14, 2025 GEXVal Inc. (President & CEO: Juran Kato, PhD; Location: Fujisawa, Kanagawa, […]